UK markets closed
NIKKEI 225
38,946.93 -122.75 (-0.31%) HANG SENG
19,220.62 -415.60 (-2.12%) CRUDE OIL
79.06 -0.74 (-0.93%) GOLD FUTURES
2,425.60 -12.90 (-0.53%) DOW
39,872.99 +66.22 (+0.17%) Bitcoin GBP
54,844.25 +45.79 (+0.08%)
CVS Jan 2025 50.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 12:52PM EDT. Market open.
| Previous close | 10.10 |
| Open | 9.65 |
| Bid | 9.45 |
| Ask | 10.15 |
| Strike | 50.00 |
| Expiry date | 2025-01-17 |
| Day's range | 9.65 - 9.90 |
| Contract range | N/A |
| Volume | |
| Open interest | 901 |
FortuneTop CVS medical officer ties shocking lack of ‘health literacy’ for 90 million Americans to crisis of ‘mistrust’
“They’re unable to gather and understand information and apply it to improve their health,” Dr. Michelle Gourdine said at Fortune’s Brainstorm Health conference.
ZacksCVS Health Corporation (CVS) is Attracting Investor Attention: Here is What You Should Know
Recently, Zacks.com users have been paying close attention to CVS Health (CVS). This makes it worthwhile to examine what the stock has in store.
PR NewswireCVS Health to present at the Bernstein 40th Annual Strategic Decisions Conference
CVS Health® (NYSE: CVS) today announced that President and CEO Karen S. Lynch and Executive Vice President and Chief Financial Officer Tom Cowhey will participate in a fireside chat with investors at the Bernstein 40th Annual Strategic Decisions Conference on May 29, 2024, at approximately 10:00 am ET.
© 2024 Yahoo. All rights reserved.